Phase
Condition
Vascular Diseases
Peripheral Arterial Disease (Pad)
Peripheral Arterial Occlusive Disease
Treatment
MicroStent
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Any subject with below the knee, at the ankle level or below the ankle peripheralarterial lesions previously treated or intended to be treated with the MicroStent®System per the current indications for use
For across the ankle joint intervention, distal runoff to digital branches orarcuate arteries must be present on angiography prior to MicroStent deployment
Subject's age is ≥ 18 years.
Subject must be willing to sign a patient informed consent form.
Exclusion
Exclusion Criteria:
Subject is pregnant or planning to become pregnant during the study duration
Subject has a life expectancy of less than one (1) year
Subject has a known allergy to concomitant medication, contrast agents (that cannotbe medically managed), anti-platelet, anti-coagulant or thrombolytic medications
Subject is enrolled in another study that has not reached its primary endpoint atthe time of enrollment.
Study Design
Study Description
Connect with a study center
Univ.-Klinikum LKH Graz
Graz,
AustriaActive - Recruiting
OLV Hospital
Aalst,
BelgiumActive - Recruiting
A.Z. Sint-Blasius
Dendermonde,
BelgiumActive - Recruiting
ZOL Genk
Genk,
BelgiumActive - Recruiting
Klinikum Hochsauerland - Karolinen Hospital
Arnsberg,
GermanyActive - Recruiting
University Heart Center Freiburg - Bad Krozingen
Bad Krozingen,
GermanyActive - Recruiting
University of Leipzig
Leipzig,
GermanyActive - Recruiting
Policlinico Abano Terme
Abano Terme,
ItalyActive - Recruiting
Maria Cecilia Hospital
Cotignola,
ItalyActive - Recruiting
St. Antonius Ziekenhuis
Nieuwegein,
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.